What is the history of Lichen Planus?

Lichen planus was first clinically defined in 1869 by the British dermatologist Erasmus Wilson, who identified the condition’s signature flat-topped, purple, itchy papules.

A Journey Through Dermatological History

Before Erasmus Wilson coined the term Lichen Planus, historical medical texts often conflated various scaly skin eruptions under the general umbrella of "lichen" or "psoriasis." Wilson’s precise observation allowed for the differentiation of Lichen Planus from other inflammatory skin disorders, marking the beginning of our formal clinical understanding. The name itself reflects the historical observation of its appearance, derived from the Greek word "leichen" (tree moss) and the Latin "planus" (flat).

Evolution of Understanding and Treatment

In the early 20th century, the recognition of oral Lichen Planus—the mucosal variant—broadened the medical perspective, shifting the view of the disease from a purely cutaneous issue to a systemic, immune-mediated condition. Historical misconceptions often linked the disease to nervous exhaustion or "psychogenic" origins, but as the 20th century progressed, researchers identified it as a T-cell-mediated autoimmune process. This shift in understanding paved the way for modern, targeted treatments. While early remedies were largely ineffective or focused on crude topical soothing, the introduction of potent topical corticosteroids in the mid-20th century transformed patient care. Later, the use of systemic immunosuppressants and phototherapy (PUVA) provided additional relief for those with widespread or refractory Lichen Planus.

Modern Advancements

Today, our understanding of Lichen Planus has been revolutionized by molecular biology. We now recognize that genetic predispositions, particularly human leukocyte antigen (HLA) associations, play a significant role in susceptibility. Technology has shifted the focus toward immunomodulatory therapies, moving away from broad-spectrum treatments toward targeted biologics currently being investigated in clinical trials. Patient advocacy has also evolved, moving from isolated experiences to active communities like those on DiseaseMaps, where collective data helps researchers identify triggers and improve the quality of life for those living with the condition.

Disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Lichen Planus


• Orphanet: Rare Disease Database


• National Library of Medicine (PubMed): Historical perspectives on Lichen Planus